Allogeneic Mesenchymal Stromal Cell Injection to Alleviate Ischemic Heart Failure Following Arterial Switch Operation.

Research output: Contribution to journalArticle (Academic Journal)peer-review

7 Downloads (Pure)

Abstract

Cell therapy is a promising tool to prevent and treat heart failure in congenital heart disease. We report the first case of intramyocardial injection of allogeneic mesenchymal stromal cells as rescue therapy in a neonate with ischemic heart failure following arterial switch procedure for isolated transposition of the great arteries. (Level of Difficulty: Advanced.).
Original languageEnglish
Pages (from-to)724-727
Number of pages4
JournalJACC. Case reports
Volume3
Issue number5
Early online date19 May 2021
DOIs
Publication statusPublished - May 2021

Bibliographical note

Funding Information:
This work was funded by the British Heart Foundation, the Sir Jules Thorn Award for Biomedical Research, and the Enid Linder Foundation. The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Publisher Copyright:
© 2021 The Authors

Fingerprint

Dive into the research topics of 'Allogeneic Mesenchymal Stromal Cell Injection to Alleviate Ischemic Heart Failure Following Arterial Switch Operation.'. Together they form a unique fingerprint.

Cite this